Arteris/$AIP
1D1W1MYTD1Y5YMAX
Capital at risk
About Arteris
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum its revenue from Asia Pacific.
- Ticker
- $AIP
- Sector
- Software & Cloud Services
- Primary listing
- NASDAQ
- Employees
- 364
- Headquarters
- Campbell, United States
- Website
- www.arteris.com
Arteris Metrics
BasicAdvanced
$1B
-
-$0.88
1.96
-
Price and volume
Market cap
$1B
Beta
1.96
52-week high
$50.26
52-week low
$8.75
Average daily volume
702K
Financial strength
Current ratio
1.568
Quick ratio
1.471
Long term debt to equity
0.087
Total debt to equity
0.128
Interest coverage (TTM)
-219.82%
Profitability
EBITDA (TTM)
-33.042
Gross margin (TTM)
87.61%
Net profit margin (TTM)
-46.70%
Operating margin (TTM)
-44.42%
Effective tax rate (TTM)
6.26%
Revenue per employee (TTM)
$230,000
Management effectiveness
Return on assets (TTM)
-14.17%
Return on equity (TTM)
-131.41%
Valuation
Price to revenue (TTM)
10.813
Price to book
14.79
Price to tangible book (TTM)
73.57
Price to free cash flow (TTM)
135.229
Free cash flow yield (TTM)
0.74%
Free cash flow per share (TTM)
0.151
Growth
Revenue change (TTM)
33.81%
Earnings per share change (TTM)
7.83%
3-year revenue growth (CAGR)
17.86%
3-year earnings per share growth (CAGR)
-3.16%
What the Analysts think about Arteris
Analyst ratings (Buy, Hold, Sell) for Arteris stock.
Analyst projections of the future price of Arteris stock.
Bulls say / Bears say
Arteris reported strong operating momentum in Q2 2026: Annual Contract Value plus royalties reached a record $99.5 million, up 44% year over year, while design starts increased 21% on a trailing-twelve-month basis. (Arteris)
The company is gaining additional exposure to AI and high-performance computing through its collaboration with IC-Link by imec, which is deploying Arteris NoC IP in next-generation AI chiplet and ASIC development. (Arteris)
Arteris expanded its relationship with Arm, with Arm engineering teams extending use of Cycuity Radix across additional next-generation CPU programs; broader adoption could strengthen Arteris’ cybersecurity product growth and customer validation. (Arteris)
Arteris remains materially unprofitable: Q2 2026 revenue was $24.1 million, but GAAP net loss reached $14.1 million, bringing first-half net loss to $22.0 million. (SEC)
The company raised $72.5 million through its at-the-market equity program during the first half of 2026, creating dilution risk for existing shareholders while operating cash flow was only $2.1 million. (SEC)
China represented 23.2% of first-half 2026 revenue, exposing Arteris to export controls, retaliatory measures, intellectual-property risks and broader U.S.-China geopolitical tensions that could restrict customer access. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 9 Sept 2026.
Arteris Financial Performance
Revenues and expenses
Arteris Earnings Performance
Company profitability
Upcoming events
No upcoming events
Arteris News
AllArticlesVideos
Funds containing Arteris
AllEURUSDGBP
Fund name | Fund size | $AIP weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.02% |
iShares MSCI World Small Cap$WSML | $9B | 0.01% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.01% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.01% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.